Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS · Delayed Price · Currency is USD
0.0500
-0.0140 (-21.88%)
Dec 31, 2025, 12:03 PM EST
PLSH Revenue
Panacea Life Sciences Holdings had revenue of $1.06M in the quarter ending March 31, 2024, with 55.94% growth. This brings the company's revenue in the last twelve months to $2.76M, up 50.38% year-over-year. In the year 2023, Panacea Life Sciences Holdings had annual revenue of $2.38M with 46.59% growth.
Revenue (ttm)
2.76M
Revenue Growth
+50.38%
P/S Ratio
1.38
Revenue / Employee
69.10K
Employees
40
Market Cap
3.81M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.38M | 757.98K | 46.59% |
| Dec 31, 2022 | 1.63M | -432.65K | -21.01% |
| Dec 31, 2021 | 2.06M | -6.96M | -77.16% |
| Dec 31, 2020 | 9.02M | 6.82M | 310.19% |
| Dec 31, 2019 | 2.20M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |
Panacea Life Sciences Holdings News
- 6 weeks ago - Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits - PRNewsWire
- 1 year ago - Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - GlobeNewsWire
- 2 years ago - Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area - GlobeNewsWire
- 2 years ago - Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise - GlobeNewsWire
- 2 years ago - Panacea Life Sciences Holdings, Inc. Celebrates National CBD Day (August 8th) By Shifting To An “Everyday Low Pricing Model” To Meet Customer Needs - GlobeNewsWire
- 2 years ago - Panacea Life Sciences Holdings, Inc. Continues Pursuit of High Growth Health and Wellness Products with Acquisition of Sierra Sage, LLC and Halucenex from Melodial Global Health (formerly Creso Pharma Limited) - GlobeNewsWire
- 2 years ago - Panacea Life Sciences Holdings, Inc. Announces CBD/CBG Clinical Trial Findings for the Management of Irritable Bowel Symptoms - GlobeNewsWire
- 2 years ago - Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast - Accesswire